Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Assessment of circular ribonucleic acid expression profiles in biofluids for the prognosis and diagnosis of congenital anomalies

FY 2020-21

Summary
If a pregnant mother's baby is in urgent need of lifesaving treatment, doesn't she deserve the right to know? What if there was a quick and effective way to assess the baby's condition and plan for the future of the baby's health? Small molecules known as biomarkers found in the amniotic fluid can provide insight into the baby's development and guide doctors to identify the next steps to ensure the birth of a healthy baby. Circular ribonucleic acids (circRNAs) are promising biomarkers for disease diagnosis. These small, stable, ring-like structures can provide information about the baby's health while in the mother's womb. Recently, we demonstrated that circRNAs can identify congenital diaphragmatic hernia (CDH); a devastating birth defect that leads to underdeveloped lungs, high blood pressure in the lungs, and a hole in the diaphragm. These same circRNAs can predict if prenatal surgery would improve chances of survival. Ultrasound, the current gold standard for CDH diagnosis, leaves one-third of cases undiagnosed. Introducing the use of circRNAs in the clinic may provide comfort to expecting mothers and help doctors bridge this gap of uncertainty. BaseScope™ is a simple and reliable technique that can visualize and quantify circRNA expression in tissue biopsies. Our lab adapted BaseScope™ to detect circRNAs in liquid biopsies such as amniotic fluid, allowing for a fast and specific analysis of circRNA expression. Our goal is to validate the differences in circRNA expression between the amniotic fluid of healthy babies and CDH babies with our adapted BaseScope™ liquid biopsy protocol. These studies will provide the first step in developing a highly sensitive, high-throughput circRNA based diagnostic tool that will allow doctors, mothers, and babies to breathe easily.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449336
Name
De Leon Nolan S
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessment of circular ribonucleic acid expression profiles in biofluids for the prognosis and diagnosis of congenital anomalies
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Basescope; Biomarker; Circular Ribonucleic Acid (Circrna); Congenital Diaphragmatic Hernia (Cdh); Epigenetics; In Situ Hybridization; Liquid Biopsy; Lung Development; Non-Coding Rnas; Prenatal Diagnostics
Abstract
If a pregnant mother's baby is in urgent need of lifesaving treatment, doesn't she deserve the right to know? What if there was a quick and effective way to assess the baby's condition and plan for the future of the baby's health? Small molecules known as biomarkers found in the amniotic fluid can provide insight into the baby's development and guide doctors to identify the next steps to ensure the birth of a healthy baby. Circular ribonucleic acids (circRNAs) are promising biomarkers for disease diagnosis. These small, stable, ring-like structures can provide information about the baby's health while in the mother's womb. Recently, we demonstrated that circRNAs can identify congenital diaphragmatic hernia (CDH); a devastating birth defect that leads to underdeveloped lungs, high blood pressure in the lungs, and a hole in the diaphragm. These same circRNAs can predict if prenatal surgery would improve chances of survival. Ultrasound, the current gold standard for CDH diagnosis, leaves one-third of cases undiagnosed. Introducing the use of circRNAs in the clinic may provide comfort to expecting mothers and help doctors bridge this gap of uncertainty. BaseScope™ is a simple and reliable technique that can visualize and quantify circRNA expression in tissue biopsies. Our lab adapted BaseScope™ to detect circRNAs in liquid biopsies such as amniotic fluid, allowing for a fast and specific analysis of circRNA expression. Our goal is to validate the differences in circRNA expression between the amniotic fluid of healthy babies and CDH babies with our adapted BaseScope™ liquid biopsy protocol. These studies will provide the first step in developing a highly sensitive, high-throughput circRNA based diagnostic tool that will allow doctors, mothers, and babies to breathe easily.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
De Leon, Nolan S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
University of Manitoba - $17,500 Grant (2020-21) | Canada Spends